Financials
Schedule 13D/G History
Ownership
Insiders
Holders
Other Reports

Roivant Sciences Ltd. - Significant Ownership

Signature - Title: Roivant Sciences Ltd. - Keyur Parekh, Authorized Signatory
Location: Hamilton Hm11, Bermuda
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Roivant Sciences Ltd..

Significant Ownership of Roivant Sciences Ltd.

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
IMVT	Immunovant, Inc.	Common Stock, par value $0.0001 per share	56.9%	$1.65B		96.7M	0%	Roivant Sciences Ltd.	Apr 21, 2025
ABUS	Arbutus Biopharma Corp	Common Shares, without par value	20.5%	$136M		38.8M	0%	Roivant Sciences Ltd.	Feb 21, 2025

Schedules 13D/G Reported by Roivant Sciences Ltd.:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Date Filed

* An asterisk sign (*) next to the price indicates that the price is likely invalid.